Our policy for adding links to other websites at
the DiabetesMonitor
-
Websites that are diabetes-related, factual, and impartial,
in the opinions of the Editors of the
DiabetesMonitor, will be added at
diabetes on the web
or
elsewhere as deemed appropriate.
Priority will be given to websites that display the
HONcode
logo.
-
Reciprocal Links:
Most healthcare websites with a bona fide link to the
DiabetesMonitor
will, upon request, have a reciprocal link placed in the
DiabetesMonitor,
at friends.
Such links elsewhere should be clearly identifiable as a deliberate addition by the webmaster of that website (e.g., within a listing of diabetes sites)
and should not be
an automated or "accidental" link (e.g., mentioned in a posting by a third party at another website's bulletin board).
However, in the event that a website
makes dubious medical claims, peer-reviewed scientific literature that is catalogued at
PubMed
(or appropriately controlled clinical trials)
will be requested and reviewed prior to our decision about whether we will link to such a website.
Any decision to not link to such a website shall be final.
The following types of websites are never appropriate for inclusion
at friends:
- Websites that (in the opinion of the Editors) prominently offer legal advice, display listings of trial lawyers, or are sponsored by law
firms and/or which appear to solicit plaintiffs for legal action,
- Websites that (in the opinion of the Editors) prominently advertise herbs or other non-FDA regulated
concoctions that pretend to treat or cure diabetes or high blood sugar.
- Websites that (in the opinion of the Editors) consist entirely or largely of listings of other websites but
do not disclose the author(s) of the website.
Non-healthcare websites will have reciprocal links added at the Editors' discretion.
- Websites may qualify to have more than one link at the
DiabetesMonitor
(e.g., if they meet both criteria (1) and (2)).
- Whether or not any organization has placed advertising with the
DiabetesMonitor
shall not influence the decision whether to place links at
DiabetesMonitor
except within clearly identified advertisements.
|
|
|